Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Richard L. Elton"'
Publikováno v:
Clinical Neuropharmacology. 9:138-145
Low-dose bromocriptine therapy (average dose 14.5 mg/day at 2 years) produced significant improvement in 25 of 39 parkinsonian patients. Brady-kinesia was less in de novo subjects; tremor and rigidity improved most in the levodopa subjects. Five of s
Autor:
R. Jeffrey Chang, Richard L. Elton, Michael O. Thorner, Mark E. Molitch, Robert B. Jaffe, Richard J. Robbins, J. E. Tyson, Richard E. Blackwell, B. Caldwell, Graham Joplin
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 60:698-705
To assess the effectiveness of bromocriptine in reducing the size of PRL-secreting macroadenomas with extrasellar extension, we conducted a prospective multicenter trial in patients without prior radiotherapy, applying a standard protocol of treatmen
Autor:
Horst F. Schran, R Lance Boyett, William S. Evans, Alan D. Rogol, Richard L. Elton, Michael O. Thorner, Donald L. Kaiser, Robert M. MacLeod, Joao L. C. Borges
Publikováno v:
Clinical Pharmacology and Therapeutics. 36:696-703
We investigated the effects of single doses of mesulergine on basal and thyrotropin-releasing hormone (TRH)-stimulated serum levels of several anterior pituitary hormones in healthy men and defined its kinetics. We also compared the effects on serum
Autor:
Ehard F. Nutting, Richard L. Elton
Publikováno v:
Experimental Biology and Medicine. 107:991-994
Summary17α-Ethynyl-4-estrene-3,17-diol diacetate is an agent that exerts unique hormonal effects. By the subcutaneous route EED is 1 to 2 times more potent than progesterone in producing proliferation of the uterine epithelium in rabbits, yet it is
BIOLOGICAL ACTIONS OF 17 α-(2-METH ALL YL)-19-NORTESTOSTERONE, AN ORALLY ACTIVE PROGESTATIONAL AGENT
Autor:
Richard L. Elton, Richard A. Edgren
Publikováno v:
Endocrinology. 63:464-472
17α-(2-Methalryl)-19-nortestosterone (SC-9022) is an active progestational agent when studied in a number of biological tests. In the intrauterine assay it was estimated to be about 10 times as active as progesterone (range 5–20 times). In the sub
Publikováno v:
Acta Endocrinologica. 41:381-390
17α-Ethynyl-4-estrene-3,17-diol and its C-3 and C-17 esterified analogues were studied for progestational, oestrogenic and androgenic properties. In addition, oestrogen-antagonistic and anti-progestational effects were determined and compared with t
Autor:
Richard L. Elton
Publikováno v:
Acta Endocrinologica. 51:543-550
Decidual responses were produced in the uteri of oestrogen-primed, progesterone treated, rabbits following traumatization of the uterus with a thread. Oestrone, administered along with progesterone, did not appear to augment the responses obtained wi
Autor:
Francis J. Saunders, Richard L. Elton
Publikováno v:
Toxicology and Applied Pharmacology. 11:229-244
Ethynodiol diacetate and mestranol, separately or in combination, prevent establishment of pregnancy in rats and rabbits when administered in sufficient dosage. This property is common to estrogens in these species. Treatment of pregnant rats with et
Autor:
Richard L. Elton
Publikováno v:
The Anatomical Record. 142:469-477
Autor:
Harrison M. Langrall, Richard L. Elton
Publikováno v:
Annals of internal medicine. 91(5)
Excerpt To the editor: The excellent and valuable review in the June issue by Drs. Spark and Dickstein, "Bromocriptine and Endocrine Disorders" (1), referred to the potential teratogenicity of this...